MapLight Therapeutics, Inc. MPLT Business Segments
| FY'25 | ||
|---|---|---|
| Research And Development Expense by Business | ||
| All Other Segments | $5.14M— | |
| Clinical Trial | $53.46M— | |
| Employee Related | $51.06M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does MapLight Therapeutics, Inc. break its business down?
- MapLight Therapeutics, Inc. (MPLT) reports research and development expense by business across 5 parts — All Other Segments, Chemistry Manufacturing And Controls Expenses, Clinical Trial, Employee Related and Preclinical Program. Each is extracted from the segment footnotes and tracked over time.
- Where does MapLight Therapeutics, Inc. 's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in MapLight Therapeutics, Inc. 's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.